Company

Hansa Biopharma

Quick facts

Emissions (ton CO₂e)

Revenue (M USD)

Intensity (t CO₂e / M USD)

In 2022, Hansa Biopharma reported a total of 6,283 ton CO₂e, and a net revenue of 15 M USD, resulting in a emissions intensity of 419 t CO₂e / M USD.

(No target data available)

Emissions, Revenue & Intensity

(No target data available to show graph)

Emissions Overview	2022
Total Emissions - Market Based (t CO₂e)
Emissions Intensity (t CO₂e / M USD)	419
Cradle-to-gate Intensity (t CO₂e / M USD)	6

Emissions Details	2022
Scope 1 Emissions (t CO₂e)	7
Scope 2 Emissions (t CO₂e)
Scope 2 - Market Based
Scope 2 - Location Based	82
Scope 2 - Not specified
Scope 3 Emissions (t CO₂e)	6,194
Upstream Emissions (t CO₂e)
1. Purchased goods and services
2. Capital goods
3. Fuel- and energy-related activities
4. Upstream transportation and distribution
5. Waste generated in operations
6. Business travel
7. Employee commuting
8. Upstream leased assets
Downstream Emissions (t CO₂e)
9. Downstream transportation and distribution
10. Processing of sold products
11. Use of sold products
12. End-of-life treatment of sold products
13. Downstream leased assets
14. Franchises
15. Investments
Total Emissions (t CO₂e)	6,283
Emission Source

Licensed under CC BY-SA 4.0